Oral squamous cell carcinoma in a Crohn's disease patient taking azathioprine: Case report and review of the literature

• Type: Another Publication in an International Scientific Journal
• Date: 2012

Authors

Vilas Boas, F (Author) Other; Magro, F (Author) FMUP; Balhau, R (Author) Other; Lopes, JM (Author) FMUP; Beca, F (Author) Other; Eloy, C (Author) Other; Lopes, S (Author) Other; Macedo, G (Author) FMUP

Journal

Title: Journal of Crohn's and Colitis

Vol. 6

Pages: 792-795

ISSN: 1873-9946

Publisher: Oxford University Press

Indexing

ISI Web of Knowledge - 12 Citations

ISI Web of Science

Scopus - 14 Citations

Pubmed / Medline

Scientific classification

CORDIS: Health sciences

Other information

Authenticus ID: P-008-PRX

DOI: 10.1016/j.crohns.2012.03.004

Abstract (EN): Thiopurines are widely used for remission maintenance and post-operative recurrence prevention in Crohn's disease. The increased risk of cancer in transplant recipients on azathioprine is well recognized and there are concerns that this may also be true for inflammatory bowel disease patients. We report a case of a 33-year-old Caucasian woman with Crohn's disease treated with azathioprine for 9. years who developed an ulcerated lesion at the right superior retromolar trigone. Biopsy specimen revealed a squamous cell carcinoma. © 2012 European Crohn's and Colitis Organisation.

Language: English

Type (Professor's evaluation): Scientific

No. of pages: 4